HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gilles Faury Selected Research

Supravalvular Aortic Stenosis (Aortic Supravalvular Stenosis)

1/2012[Elastin and microfibrils in vascular development and ageing: complementary or opposite roles?].
12/2009Discrete contributions of elastic fiber components to arterial development and mechanical compliance.
11/2008Elastin insufficiency predisposes to elevated pulmonary circulatory pressures through changes in elastic artery structure.
2/2008Elastin haploinsufficiency induces alternative aging processes in the aorta.
11/2003Developmental adaptation of the mouse cardiovascular system to elastin haploinsufficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gilles Faury Research Topics

Disease

6Hypoxia (Hypoxemia)
06/2022 - 11/2008
5Supravalvular Aortic Stenosis (Aortic Supravalvular Stenosis)
01/2012 - 11/2003
4Marfan Syndrome (Marfan's Syndrome)
01/2012 - 12/2009
3Hypertension (High Blood Pressure)
01/2021 - 11/2003
3Aortic Aneurysm (Aneurysm, Aortic)
01/2012 - 11/2010
2Vascular Remodeling
06/2022 - 11/2008
2Inflammation (Inflammations)
01/2018 - 02/2013
2Williams Syndrome (Williams-Beuren Syndrome)
01/2012 - 02/2008
1Infarction (Infarctions)
06/2022
1Hypertrophy
06/2022
1Fibrosis (Cirrhosis)
06/2022
1Atherosclerosis
06/2022
1Atherosclerotic Plaque (Atheroma)
01/2022
1Cardiomegaly (Heart Hypertrophy)
01/2020
1Arteriosclerosis
11/2019
1Myocardial Infarction
02/2013
1Hypersensitivity (Allergy)
02/2013
1Pathologic Constriction (Stenosis)
01/2012
1Cardiovascular Diseases (Cardiovascular Disease)
10/2009
1Ischemia
10/2009
1Angina Pectoris
10/2009
1Pulmonary Arterial Hypertension
11/2008
1Right Ventricular Hypertrophy
11/2008
1Vascular Diseases (Vascular Disease)
02/2008
1Sepsis (Septicemia)
09/2005
1Cardiovascular Abnormalities
01/2004
1Essential Hypertension
11/2003
1Glucose Intolerance
07/2003

Drug/Important Bio-Agent (IBA)

7ElastinIBA
01/2021 - 11/2003
4Fibrillin-1IBA
01/2012 - 12/2009
2Phosphotransferases (Kinase)IBA
06/2022 - 10/2021
2Apolipoproteins E (ApoE)IBA
06/2022 - 01/2022
2cadherin 5IBA
06/2022 - 10/2021
2AntioxidantsIBA
10/2021 - 10/2009
2Nicorandil (SG 75)IBA
10/2009 - 10/2009
2Glucose (Dextrose)FDA LinkGeneric
01/2004 - 07/2003
1Oxygen (Dioxygen)IBA
06/2022
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
06/2022
1saracatinibIBA
06/2022
1AcriflavineIBA
06/2022
1pazopanibFDA Link
06/2022
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2021
1Tyrosine (L-Tyrosine)FDA Link
10/2021
1Dihydrotachysterol (AT 10)IBA
01/2020
1TropoelastinIBA
01/2020
1LipidsIBA
11/2019
1Endothelins (Endothelin)IBA
10/2018
1Protein Isoforms (Isoforms)IBA
01/2018
1Myosin-Light-Chain KinaseIBA
01/2018
1Atorvastatin (Lipitor)FDA Link
02/2013
1Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2013
1FibrillinsIBA
01/2012
1Glycoproteins (Glycoprotein)IBA
11/2010
1Adenosine Triphosphate (ATP)IBA
10/2009
1Nitric Oxide DonorsIBA
10/2009
1Peptides (Polypeptides)IBA
09/2005
1Proteins (Proteins, Gene)FDA Link
11/2003

Therapy/Procedure

1Continuous Positive Airway Pressure
10/2021